Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2022 1
2023 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

3 results

Results by year

Filters applied: . Clear all
Page 1
Tumor Suppressor Role of INPP4B in Chemoresistant Retinoblastoma.
Miroschnikov N, Dräger O, Van Meenen D, Metz K, Budeus B, Dünker N, Busch MA. Miroschnikov N, et al. Among authors: van meenen d. J Oncol. 2023 Mar 8;2023:2270097. doi: 10.1155/2023/2270097. eCollection 2023. J Oncol. 2023. PMID: 36993823 Free PMC article.
ADAM10 and ADAM17-Novel Players in Retinoblastoma Carcinogenesis.
Van Meenen D, Doege A, Alefeld E, Haase A, Beier M, Kiefer T, Biewald E, Metz K, Dräger O, Busch MA, Dünker N. Van Meenen D, et al. Int J Mol Sci. 2022 Oct 20;23(20):12621. doi: 10.3390/ijms232012621. Int J Mol Sci. 2022. PMID: 36293469 Free PMC article.
New retinoblastoma (RB) drug delivery approaches: anti-tumor effect of atrial natriuretic peptide (ANP)-conjugated hyaluronic-acid-coated gold nanoparticles for intraocular treatment of chemoresistant RB.
Haase A, Miroschnikov N, Klein S, Doege A, Dünker N, Van Meenen D, Junker A, Göpferich A, Apaolaza PS, Busch MA. Haase A, et al. Among authors: van meenen d. Mol Oncol. 2024 Apr;18(4):832-849. doi: 10.1002/1878-0261.13587. Epub 2024 Jan 12. Mol Oncol. 2024. PMID: 38217258 Free PMC article.